• InforMedix Holdings (Rockville, Maryland) said it would co-brand its MedeMonitor patient diary and medication dispensing device with McKesson BioServices, a division of McKesson (San Francisco). McKesson BioServices will market, sell and distribute the co-branded device to facilitate clinical trials. The McKesson Med-eMonitor integrates medication packaging, medication compliance, and an electronic patient diary, resulting in improved medication compliance and capture of patient dose-response data. Additional features include the ability to record the exact time of dosing and deliver a therapy that uses more than one drug; rapid and accurate reporting of adverse experiences; and the potential to detect medication compliance problems and to quickly develop protocol changes.

• Maxell Corp. of America (Fair Lawn, New Jersey) reported new ultra-durable and ultra-reliable DVD media designed specifically for the medical market. Maxell's medical-grade media incorporates the Maxpro Hardcoat technology to produce enhanced DVD-R media that delivers the highest level of data protection for up to twice the archival shelf life. Maxell Medical DVD-R is HIPAA- and DICOM-compliant, and with its superior scratch, dust and smudge resistance and extended archival life, is ideal for critical medical images, patient records, backup and fixed content storage. Maxell Medical DVD-R's hard-coat top layer delivers increased data longevity and protection for twice the archival and storage lifespan. Maxell Medical DVD-R will have a capacity of 700 MB and will be able to store up to 700 X-rays or 550 high-resolution images. Maxell's 700 MB, 8X speed Medical DVD-R media will be available in March as a single disc in a jewel case and in 50-pack spindles with printable white surfaces for either thermal or inkjet printers.

• Neoprobe (Dublin, Ohio), a developer of oncology and cardiovascular surgical and diagnostic products, said it has received notification that its 510(k) application for the revised and enhanced Quantix/OR blood flow measurement has been accepted by the FDA for review. In addition, Neoprobe said it has completed the necessary regulatory steps to begin marketing the product in the European Union. The company reintroduced the Quantix/OR at a joint meeting of the German, Austrian and Swiss cardiovascular surgical society meeting in Hamburg, Germany, last weekend. The Quantix/OR has been revised to enhance visual ergonomics and to facilitate surgeon use. The flexible probe configuration will permit surgeons to access vessels for measurement during both on- and off-pump by-pass procedures. The company said it is planning full product re-introduction at the American Association for Thoracic Surgery meeting in April.

• Regeneration Technologies (RTI; Alachua, Florida), a processor of orthopedic, cardiovascular and other allograft implants, said that its bone paste product has received 510(k) clearance from the FDA. RTI's demineralized bone matrix (DBM) paste products consist of allograft DBM and a gelatin carrier. RTI allograft pastes are used in spinal and orthopedic procedures to fill voids in bone. The pastes are insoluble in fluids at body temperature, so they stay in place during irrigation. The DBM products are packaged and marketed under different names depending on the application, including Regenafil Allograft Paste; Regenafil RT Allograft Paste; Optefil Allograft Paste, Syringe; Optefil RT Allograft Paste, Syringe; Optefil DBM Paste; Osteofil RT DBM Paste and RTI Allograft Paste.

• SoftMed Systems (Silver Spring, Maryland), a provider of healthcare information solutions, reported the release of ScriptHD, a new mobile healthcare documentation solution. The application enables users to capture clinical information on the desktop, laptop and mobile, handheld computers. By offering the flexibility to create, review, and edit clinical records through a choice of data entry options, ScriptHD enables clinicians to acquire clinical data, improve the quality of the documentation, and increase the amount of time spent with patients. ScriptHD includes structured documentation that minimizes input from the clinician. Documents are automatically created and distributed and built-in coding increases billing and reimbursement efficiency and accuracy. In addition, ScriptHD enables clinical data to be stored in a database for simultaneous access. ScriptHD is available to healthcare facilities in the form of modules geared specifically toward a medical specialty. A physical therapy module is available to help bring both inpatient and outpatient physical therapy settings into the mainstream, with a centralized process for creating documents and the ability to integrate with hospitals' main information management systems.

• WiFiMed (Maynard, Massachusetts), a provider of a tablet-based solution to collect and manage patient medical information, reported the launch of Tablet MD, an integrated, physician-personalized solution to manage the flow of new and historical patient care information in medical practices. Tablet MD meets HIPAA requirements and easily and securely integrates with existing physician practice management, lab and other systems to help facilitate widespread adoption of healthcare IT. With Tablet MD, physicians can manage all patient information based on the patient's specific medical history, and document the entire physician-patient encounter, using medical knowledge, forms, checklists, handwriting, drawing and voice. Tablet MD has the look, feel and form factor of the physician's current paper records, allowing for a smooth transition to electronic records. Tablet MD runs on a Tablet PC that provides physicians with light, mobile access to critical patient history, data and test results while in the office, at home or on rounds.

No Comments